Market Cap 2.00B
Revenue (ttm) 167.13M
Net Income (ttm) -4.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 748.90
Profit Margin -2.41%
Debt to Equity Ratio 0.00
Volume 81,700
Avg Vol 113,436
Day's Range N/A - N/A
Shares Out 19.29M
Stochastic %K 96%
Beta 0.83
Analysts Strong Sell
Price Target $144.56

Latest News on LGND

Ligand to Ring the Nasdaq Opening Bell on May 19, 2025

May 14, 2025, 7:00 AM EDT - 22 days ago

Ligand to Ring the Nasdaq Opening Bell on May 19, 2025


Ligand Reports First Quarter 2025 Financial Results

May 8, 2025, 7:00 AM EDT - 4 weeks ago

Ligand Reports First Quarter 2025 Financial Results


Ligand to Participate in May Investor Conferences

May 1, 2025, 7:00 AM EDT - 5 weeks ago

Ligand to Participate in May Investor Conferences


Ligand to Participate in March Investor Conferences

Mar 3, 2025, 7:00 AM EST - 3 months ago

Ligand to Participate in March Investor Conferences


Looking Back On Ligand Pharmaceuticals

Feb 3, 2025, 2:59 PM EST - 4 months ago

Looking Back On Ligand Pharmaceuticals


Ligand to Present at Stifel 2024 Healthcare Conference

Nov 14, 2024, 8:00 AM EST - 7 months ago

Ligand to Present at Stifel 2024 Healthcare Conference


Ligand Reports Second Quarter 2024 Financial Results

Aug 6, 2024, 4:01 PM EDT - 10 months ago

Ligand Reports Second Quarter 2024 Financial Results


Ligand Pharmaceuticals: Solid Performer Performing Solidly

Jul 29, 2024, 2:43 PM EDT - 11 months ago

Ligand Pharmaceuticals: Solid Performer Performing Solidly


Ligand to Acquire APEIRON Biologics AG for $100 Million

Jul 8, 2024, 7:00 AM EDT - 11 months ago

Ligand to Acquire APEIRON Biologics AG for $100 Million


Ligand to Participate in Upcoming Investor Conferences

May 23, 2024, 4:59 PM EDT - 1 year ago

Ligand to Participate in Upcoming Investor Conferences


Ligand Reports First Quarter 2024 Financial Results

May 7, 2024, 4:00 PM EDT - 1 year ago

Ligand Reports First Quarter 2024 Financial Results


Ligand Pharma's at-home skin treatment gets FDA approval

Jan 5, 2024, 5:21 PM EST - 1 year ago

Ligand Pharma's at-home skin treatment gets FDA approval